PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells. uri icon

authors

  • Chen, Ziyu
  • Gutierrez-Arcelus, Maria
  • Brennan, Patrick J
  • Padera, Timothy P
  • von Andrian, Ulrich
  • Mehrara, Babak
  • Greene, Arin K
  • Kahn, C Ronald
  • Orgill, Dennis P
  • Indranil Sinha, MD
  • Rosen, Vicki
  • Ghavimi, Soheila Ali Akbari
  • Agarwal, Shailesh
  • Wu, Mengfan
  • McNamara, John
  • Barreiro, Olga
  • Maridas, David
  • Kratchmarov, Radomir
  • Siegel, Ashley
  • Djeddi, Sarah

publication date

  • December 22, 2023